Cetera Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Cetera Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,956	Closed	-$223K	–	1746
2022 Q4	$223K	Buy	+1,956	New	+$162K	﹤0.01%	1391
2022 Q1	–	Sell	-1,909	Closed	-$206K	–	1558
2021 Q4	$206K	Buy	+1,909	New	+$208K	﹤0.01%	1314
2015 Q4	–	Sell	-14,653	Closed	-$291K	–	774
2015 Q3	$291K	Buy	14,653 +5,662	+63%	+$179K	0.03%	501
2015 Q2	$313K	Buy	8,991 +170	+2%	+$5.19K	0.03%	508
2015 Q1	$229K	Buy	+8,821	New	+$162K	0.02%	592

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return